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The Effects on Increasing Cardiac Output with Adrenaline
or Isoprenaline on Arterial Haemoglobin Oxygen Saturation
and Shunt During One-Lung Ventilation
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SUMMARY
Theoretically, if the cardiac output were increased in the presence of a given intrapulmonary shunt, the arterial
haemoglobin oxygen saturation (SaO2) should improve as the venous oxygen extraction per ml of blood decreases. To
test this hypothesis, eight pigs were subjected to one-lung ventilation and adrenaline and isoprenaline infusions used
to increase the cardiac output. The mixed venous oxygen, shunt fraction and oxygen consumption were measured. 
With both adrenaline and isoprenaline, although there was a small rise in mixed venous oxygen content, there was
a fall in SaO2. With adrenaline, the mean shunt rose from 48% to 65%, the mean oxygen consumption rose from 
126 ml/min to 134 ml/min and the mean SaO2 fell from 86.9% to 82.5%. With isoprenaline, the mean shunt rose
from 45% to 59%, the mean oxygen consumption rose from 121 ml/min to 137 ml/min and the mean SaO2 fell from
89.5% to 84.7%. 
It is concluded that potential improvement in SaO2, which might occur from a catecholamine-induced increase in
mixed venous oxygen content during one-lung ventilation, is more than offset by increased shunting and oxygen
consumption which reduce SaO2.
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One-lung ventilation is commonly used for
intrathoracic procedures. Occasionally, in spite of an
optimal position of the double-lumen tube, major
decreases in SaO2 occur. With 100% inspired oxygen
and a given oxygen consumption, the degree of
desaturation is dependant on only two factors, the
shunt fraction and the level of desaturation in the
mixed venous blood. For a given shunt fraction, the
SaO2 will rise as the mixed venous oxygen content
rises. Thus one possible approach to minimizing the
decrease in SaO2 would be to elevate the mixed
venous oxygen content.
The oxygen content of mixed venous blood is deter-
mined by the initial level of arterial oxygen content,
the tissue oxygen uptake and the cardiac output. If
the oxygen tissue uptake (oxygen consumption)
remains unaltered, increasing the cardiac output
should result in a higher mixed venous oxygen
content and a better arterial oxygen saturation as a
consequence. Thus the SaO2 during one-lung anaes-
thesia should improve if the cardiac output could be
increased without increasing the shunt fraction or the
oxygen uptake. To test this hypothesis we stimulated
the cardiac output with adrenaline or isoprenaline in
pigs who were being ventilated using one-lung under
general anaesthesia.
METHODS
This study was approved in advance by the animal
ethics committee of the University of Cape Town.
Pigs weighing between 23 and 25 kg were pre-
medicated intramuscularly with ketamine 300 mg,
diazepam 2.5 mg and atropine 0.6 mg. After the pig
was very drowsy, a cannula was inserted into an ear
vein and thiopentone administered intravenously
until the animal was unconscious. The pig was then
intubated with a 7.0 mm cuffed tracheal tube, pan-
curonium 8 mg administered and the lungs ventilated
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with oxygen and 1% halothane. Arterial cannulation
was established by a cut-down into the right carotid
artery. A pulmonary artery catheter was placed via
the right external or internal jugular vein. Halothane
administration was varied between 0.5% and 2% as
determined by the arterial blood pressure and heart
rate. Additional pancuronium 2 mg and ketamine 
100 mg were administered every half hour to main-
tain haemodynamic stability and to ensure an
adequate depth of anaesthesia. Nasopharyngeal tem-
perature was monitored and the temperature main-
tained between 35.5 and 37.5°C with hot air warming.
Heart rate (ECG) and blood pressure were
monitored continuously and recorded every minute
directly from the monitor into a computer.
Once monitoring had been established, a
tracheostomy was made and the tracheal tube
replaced by a 35 Fr left-sided double-lumen endo-
bronchial tube through the tracheostomy. The
bronchial cuff was inflated to achieve a seal in the
trachea.  The lung inflation pressure was noted
(usually about 25 cmH2O) and with the cuff inflated,
the tube advanced about 1cm with each breath.
Placement of the tube in the left main bronchus was
evidenced by a firm resistance to further advance-
ment, a fall in lung compliance (as seen by a sharp
rise in inflation pressure for the set tidal volume),
asymmetry of chest movement and breath sounds and
a sharp fall in SaO2. Once this was achieved, the cuff
was deflated and the tube moved in a further 15 mm.
The tube was then sutured to the skin to reduce
further movement.
Ventilation was adjusted to achieve a PaCO2
between 30 and 45 mmHg. Cardiac output was
measured in triplicate by cold thermodilution.
Duplicate arterial and mixed venous samples for
analysis of PO2, haemoglobin oxygen saturation and
PCO2 were taken and the cardiac output again
measured in triplicate. Haemoglobin concentration
was measured. The shunt fraction was calculated with
the standard equations using an alveolar oxygen pres-
sure of 100% less water vapour and arterial CO2 ten-
sion. Oxygen consumption was calculated as the dif-
ference between the arterial and venous oxygen con-
tent multiplied by the averaged pre-sample and post-
sample cardiac outputs.
Cardiac output was then stimulated by an intra-
venous infusion of adrenaline or isoprenaline. The
initial infusion for adrenaline was 1 µg.min–1 and for
isoprenaline was 0.2 µg.min–1. The first drug used on
each pair of pigs was selected randomly by the toss 
of a coin; the second pig of the pair received the
opposite sequence of sympathomimetic drugs.
The rate of drug infusion was increased every two
minutes. The aim was to achieve at least a 30%
increase in cardiac output. Once a satisfactory
increase in cardiac output had been achieved, the
infusion was maintained for 10 minutes and a tripli-
cate set of cardiac output measurements taken. This
was followed by arterial and mixed venous blood
samples taken in duplicate and finally a further set of
triplicate cardiac output measurements.
The sympathomimetic infusion was then ceased
and the heart rate and cardiac output allowed to
settle usually within ±10% of the previous values.
After 15 minutes the cardiac output and blood gases
were again measured. The second infusion was then
commenced to the same target increase in cardiac
output. Once the values had been stable for 10
minutes, cardiac output and blood gases were
measured. The infusion was stopped and after a
further 15 minutes the measurements repeated.
Changes in output and other parameters were
measured against the average value of the preceding
and following control states.
At the end of the experiment the pig was killed with
an overdose of thiopentone and intravenous air. The
bronchial tree and lungs were subjected to a post
mortem examination to ensure that ventilation of
only the left lung had been achieved. At this time, the
presence and position of an upper lobe bronchus
supplying either lung arising directly from the trachea
was also examined.
Statistical analysis was done using Statview 5.0
(SAS) and Instat 2. For most comparisons, a paired 
t test was used. For all probabilities, a two-tailed test
was used. In the results, mean values are given with
standard deviations.
RESULTS
The experimental protocol was completed in eight
pigs. All pigs had a direct bronchial airway from the
trachea to the right upper lobe. In all animals, the
final intubation had excluded the right lung. In seven
of the eight pigs, the intubation had excluded also the
bronchial branch to the left upper lobe.
Cardiac Outputs
The control cardiac outputs ranged from 2.3 to 
4.3 l/min. The percentage increase in cardiac output
with adrenaline ranged from 54% to 87% and with
isoprenaline from 31% to 110%.
Mixed Venous Oxygen Contents
Mixed venous oxygen content rose with all adrena-
line and isoprenaline infusions. The mean increase
with adrenaline was 1.66±1.03 ml%, range 0.42 to
3.34 (P=0.003). The mean increase with isoprenaline
was 0.64±0.43 ml% range 0.04 to 1.134 (P=0.004).
Arterial Haemoglobin Oxygen Saturation
The control SaO2 varied from 69.0% to 99.6%,
with a mean of 86.9±7.9%. During adrenaline infu-
sion, the mean SaO2 varied from 64.5% to 96% with
a mean of 82.5±10.6%. The mean change in SaO2
was =4.4±3.5%, t=3.54, P=0.0094. The control
SaO2 for isoprenaline varied from 80.9% to 100%,
with a mean of 89.5±5.8%. During isoprenaline infu-
sion, the SaO2 varied from 68.8% to 96.4% with a
mean of  84.7±7.7%. The mean change in SaO2 was
4.8± 3.6%, t=3.76, P=0.0071.
Shunt
For the whole group, the control shunt was
48.1±6.9%. After the administration of adrenaline,
the shunt increased to 64.9±7.8%. The mean differ-
ence between control shunt and the shunt during
adrenaline infusion was 16.8±5.9% (paired t=8.1,
P<0.0001) (Figure 1).
The control shunt prior to the administration of
isoprenaline was 44.9±7.4% which is not significantly
different from the adrenaline control (P=0.39).
During the isoprenaline infusion, the mean shunt
increased to 59.3±3.7% which was again not signifi-
cantly different from the shunt during the adrenaline
infusion, but was significantly greater than the control
shunt. The mean difference in shunt from control for
the isoprenaline infusions was 14.3±4.7% (paired 
t=8.6, P<0.0001) (Figure 2).
Oxygen Consumption
For the whole group, the mean control oxygen
consumption was 126.2±30.2 ml/min. After the
administration of adrenaline, the mean consumption
increased to 133.8±43.7 ml/min. The mean difference
between control and the oxygen consumption during
adrenaline infusion was 7.7±25.6 ml/min (paired 
t=0.85, P=0.42) (Figure 3). 
Similarly during the administration of isoprenaline,
oxygen consumption increased from the control value
of 120.5±15.9 ml/min to 137.0±26.6 ml/min with a
mean individual change of 16.6±18.4 ml/min, (paired
t=2.6, P=0.038) (Figure 4). The control pre- and
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FIGURE 1: The effect of adrenaline infusion on the shunt. In all
pigs the shunt increased; the mean (SD) increase was 16.8±5.9%,
t=8.1, P<0.0001.
FIGURE 2: The effect of isoprenaline infusion on the shunt. In all


















FIGURE 3: Change in oxygen consumption with an adrenaline
infusion. Although there is a tendency to increase consumption;















post-isoprenaline values for oxygen consumption
were not significantly different from those pre- and
post-adrenaline.
Other Changes
Three control measurements of shunt and oxygen
consumption were made on each animal; an initial
measurement was made before the first infusion and
then two further measurements, one after each infu-
sion. These control measurements of shunt were not
significantly different between each of the three times
(one-way ANOVA F=0.16, P=0.85) (Figure 5).
However, the oxygen consumption at the control
intervals showed a progressive increase during the
experiment (one-way ANOVA F=4.3, P=0.027)
(Figure 6).
The increases in shunt and in oxygen consumption
that accompanied the administration of adrenaline
and of isoprenaline were individually only weakly
correlated with the increase in cardiac output which
occurred. However, the effect was more apparent
when the two catecholamines were combined, both
for shunt and for oxygen consumption (Figure 7 and
Figure 8 respectively).
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FIGURE 4: Changes in oxygen consumption with the infusion 
of isoprenaline. Overall, there was an increase in oxygen









FIGURE 5: Percentage shunt and standard deviation for the eight
pigs at each of the three control periods. There is no significant















FIGURE 6: Percentage oxygen consumption and standard deviation
for the eight pigs at each of the three control periods. There is a
significant difference with respect to time. (One way ANOVA
F=4.3, P=0.027.)
FIGURE 7: Relationship between cardiac output (x) and shunt (y).
The regression equation is: y=0.45x –40.0 r=0.61, P=0.013.
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DISCUSSION
In contrast to the study by Mouton et al1 where the
apical bronchus arising from the trachea was equally
distributed between the right and left sides, the eight
pigs in these experiments all had the right apical
bronchus arising from the trachea. This simplified the
protocol in that when the double-lumen tube was
inserted into the left main bronchus for left lung ven-
tilation, the right apical bronchus was excluded from
ventilation with the rest of the right lung.
It is clear that in this pig model, in spite of an
improved mixed venous oxygen, the use of either
adrenaline or isoprenaline to boost cardiac output is
associated with a significant decrease in SaO2, in
direct contradiction to the original hypothesis. This
result is attributable to the effects of sympatho-
mimetic stimulation on intrapulmonary shunting and
oxygen consumption. The increased shunt could be
the result of either inhibition of hypoxic vasoconstric-
tion or direct intrapulmonary vasodilatation. Studies
by Furman et al2 and Marin3 have shown that isopre-
naline and dobutamine have pulmonary vasodilator
properties that may inhibit hypoxic pulmonary vaso-
constriction, although this has not been tested in a
model with an atelectatic lung. It has also been sug-
gested that vasoconstrictor drugs such as phenyle-
phrine may preferentially constrict vessels in norm-
oxic lung, thus increasing the flow through the 
hypoxic areas4. Our data cannot distinguish the
effects of increased oxygen consumption and vaso-
dilation increasing the shunt, but the net result is
further desaturation of the arterial blood. Increased
oxygen consumption reduces the rise in mixed venous
oxygen expected with increased cardiac output. These
effects outweigh the potential benefit of increased
cardiac output increasing oxygen delivery to the
tissues. The small rise in mixed venous oxygen con-
tent could indicate improved tissue oxygen delivery
but may also be due to increased capillary shunting
and reduced tissue oxygen delivery. Only direct tissue
oxygen tension measurement could resolve these
possibilities.
Although cardiac stimulants other than adrenaline
and isoprenaline may be able to increase the cardiac
output without adverse effects, the present evidence
suggests that most potent inotropes do increase
oxygen consumption5. Of the presently available
inotropic agents, only dopamine appears not to
increase oxygen consumption and thus may be of
benefit6, although there are no direct data that we are
aware of to support this possibility. Whether other
inotropic agents would produce similar increases in
intrapulmonary shunting is uncertain, but it seems
likely that any agent with significant beta-adrenergic
activity would be likely to cause a similar degree of
pulmonary vasodilation.
Although the 15 minute control periods were
adequate to restore normal haemodynamic function
and to reverse the adverse effects of intrapulmonary
shunting, there was a progressive increase in oxygen
consumption throughout the experiment. This in-
crease in metabolic rate may be produced by a cate-
cholamine effect which significantly outlasts the
haemodynamic effects. It is possible that a longer
control period between catecholamine infusions may
have allowed more complete reversal of the meta-
bolic effects. We could find no reported data on the
duration of the metabolic effects of catecholamines in
an intact animal model.
The correlation between the increase in cardiac
output and both the increased shunt and the
increased oxygen consumption for either type of
catecholamine stimulation suggests that increasing
cardiac output by the use of catecholamines will
inevitably be offset by increases in oxygen consump-
tion and in shunt. The results of this study strongly
suggest that any attempt to improve SaO2 during one-
lung anaesthesia by stimulation of cardiac output with
catecholamines is unlikely to be beneficial. The value
of catecholamines with a greater vasoconstrictor
effect remains to be investigated.
In conclusion, although enhancing the cardiac out-
put with a catecholamine infusion might theoretically
improve the SaO2 for a given fixed shunt during one-
lung anaesthesia, these experiments in pigs do not
FIGURE 8: Relationship between cardiac output (x) and oxygen
consumption (y). The regression equation is: y=0.43x+37.3
r=0.52, P=0.039.
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support this hypothesis. An infusion of either adrena-
line or isoprenaline is associated with an increased
shunt and an increased oxygen consumption. These
two effects more than offset any beneficial effect of
an improved cardiac output on SaO2..
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